Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7 pseudogene 6 (RPL7P6) is a processed pseudogene in the human genome, derived from the ribosomal protein L7 (RPL7) gene. As a pseudogene, RPL7P6 does not encode a functional protein and is not believed to be involved in known human pathologies or normal biological processes. Multiple processed pseudogenes for ribosomal protein L7 exist throughout the human genome, byproducts of gene duplication and retrotransposition events. Most pseudogenes, including RPL7P6, are considered non-functional, though some may have minor regulatory potential at the RNA level. RPL7P6 is not considered a therapeutic or pharmacological target, nor is it associated with drug interaction, disease, or biomarker applications[2][5][8][9][12][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7 pseudogene 6 (RPL7P6).